Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) Therapy on Dementia and Cognitive Decline
Antonio Lardaro, L. Quarta, Stefania Pagnotta, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1750-1750
Open Access | Times Cited: 18

Showing 18 citing articles:

Amyloid-β and heart failure in Alzheimer’s disease: the new vistas
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Hamdoon A. Mohammed, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 4
Alzheimer’s Disease as Type 3 Diabetes: Understanding the Link and Implications
Mateusz Kciuk, Weronika Kruczkowska, Julia Gałęziewska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11955-11955
Open Access | Times Cited: 11
Comparative Effectiveness of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Preventing Alzheimer's Disease, Vascular Dementia, and Other Dementia Types Among Patients with Type 2 Diabetes
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes & Metabolism (2025), pp. 101623-101623
Closed Access | Times Cited: 1
Quantifying Cognitive Function in Diabetes: Relationships Between AD8 Scores, HbA1c Levels, and Other Diabetic Comorbidities
Hsin-Yu Chao, Ming-Chieh Lin, Tzu‐Jung Fang, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 340-340
Open Access
Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer’s disease in type 2 diabetes
Prakash Ramakrishan, Jayaraman Rajangam, Shaheedha Shabudeen Mahinoor, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 3
Closed Access
Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)
Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко, et al.
Innovative medicine of Kuban (2025) Vol. 10, Iss. 1, pp. 101-109
Open Access
Dapagliflozin Modulates MicroRNA Expression in Type 2 Diabetes Patients with Diabetic Nephropathy: A Retrospective Study
Deniz YILDIZ PEHLİVAN, Hamit Yıldız, Gönen Kaya
European Journal of Therapeutics (2025) Vol. 31, Iss. 1, pp. 1-10
Open Access
Comparative risk of dementia in diabetic stroke patients prescribed SGLT2 vs. DPP-4 inhibitors: A propensity-matched retrospective cohort study
Pei-Chun Chiang, Cheng-Yang Hsieh, Sheng‐Feng Sung
Journal of Stroke and Cerebrovascular Diseases (2025), pp. 108276-108276
Open Access
Diabetes Mellitus and Cognitive Decline: A Systematic Review Exploring the Link to Dementia and Neurodegenerative Diseases
Abdul Khaliq, Aroon Kumar, Mahnoor Khan, et al.
Cureus (2025)
Open Access
SGLT-2i—A Useful Tool for Real-Life Metabolic and Body Weight Control in Type 2 Diabetes Mellitus Patients
Mihaela-Simona Popoviciu, Teodor Salmen, Delia Reurean‐Pintilei, et al.
Medicina (2025) Vol. 61, Iss. 3, pp. 548-548
Open Access
Reducing Alzheimer’s Disease Risk with SGLT2 Inhibitors: From Glycemic Control to Neuroprotection
Mehdi Alami, Mojgan Morvaridzadeh, Abdellatif El Khayari, et al.
Ageing Research Reviews (2025), pp. 102751-102751
Closed Access
Sodium‐glucose cotransporter‐2 inhibitors and subtype‐specific dementia risk: A multinational and multiethnic cohort study
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Comparative study of SGLT2 inhibitors and metformin: evaluating first-line therapies for dementia prevention in type 2 diabetes
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes & Metabolism (2025), pp. 101655-101655
Closed Access
Semaglutide and High-Intensity Interval Exercise Attenuate Cognitive Impairment in Type 2 Diabetic Mice via BDNF Modulation
Sijie Lai, Zhenghong Kang, Jing Sun, et al.
Brain Sciences (2025) Vol. 15, Iss. 5, pp. 480-480
Open Access
Exploring the Association Between Cognitive Decline and Triglyceride‐Glucose Index: A Systematic Review and Meta‐Analysis
Elina Ghondaghsaz, Amirmohammad Khalaji, Mehrdad Mahalleh, et al.
Brain and Behavior (2024) Vol. 14, Iss. 11
Open Access | Times Cited: 2
Metabolic Syndrome, Kidney-Related Adiposity, and Kidney Microcirculation: Unraveling the Damage
Kyu Won Jang, Jin Hur, Jeong Yong Lee, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2706-2706
Open Access | Times Cited: 1
Predictive Factors for Urinary Tract Infections in Patients with Type 2 Diabetes
Teodora Sorescu, Andrei Cosnita, Adina Braha, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7628-7628
Open Access
Human Endogenous Retroviruses and Their Putative Role in Pathogenesis of Alzheimer’s Disease, Inflammation, and Senescence
Patrycja Kozubek, Julia Kuźniar, Magdalena Czaja, et al.
Biomedicines (2024) Vol. 13, Iss. 1, pp. 59-59
Open Access
Exploring the Molecular Modalities in the Pathogenesis of Diabetic Kidney Disease with a Focus on the Potential Therapeutic Implications
Lyubomir Gaydarski, Kristina Petrova, Ivan Angushev, et al.
Biomedicines (2024) Vol. 13, Iss. 1, pp. 50-50
Open Access
Page 1

Scroll to top